Intrauterine Embryo Development With ANECOVA Device
Launched by INSTITUTO VALENCIANO DE INFERTILIDAD, IVI VALENCIA · May 29, 2007
Trial Information
Current as of July 21, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Women age below 37
- • Hormonal serum levels within normal ranges (FSH, LH, E2, PRL, P4, T4, TSH)
- • Negative serologic screening for HIV, Hep B and C
- • No uterine or ovarian alterations found by ultrasound
- • Normal BMI (19 - 29 kg/m2).
- Exclusion Criteria:
- • At least 8 stage MII oocytes are not retrieved
- • Endometriosis or PCO
- • Severe male factor in the partner
About Instituto Valenciano De Infertilidad, Ivi Valencia
Instituto Valenciano de Infertilidad (IVI Valencia) is a leading fertility clinic and research institution dedicated to advancing reproductive health and assisted reproductive technologies. With a commitment to providing personalized care and innovative treatment options, IVI Valencia conducts clinical trials aimed at enhancing the understanding and effectiveness of infertility therapies. The institute combines state-of-the-art facilities with a team of experienced specialists, ensuring high standards of patient safety and ethical research practices. IVI Valencia plays a pivotal role in fostering scientific advancements in the field of reproductive medicine, ultimately striving to improve outcomes for individuals and couples facing fertility challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Patients applied
Trial Officials
Martin Velasco
Study Director
Affiliated
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials